Variant · Snv
PPARA NM_005036.6(PPARA):c.484C>G (p.Leu162Val)
CI-VAR-00006224Explore in graph →p.Leu162ValNM_005036.6:c.484C>GClinVar 13701 rs1800206
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 13701 | Benign | no assertion criteria provided | 0 | Hyperapobetalipoproteinemia, susceptibility to; Adrenocortical carcinoma, hereditary; Thymoma; Hepatocellular carcinoma; Uveal melanoma; Malignant lymphoma, large B-cell, diffuse; Colon adenocarcinoma; Colorectal cancer; Uterine carcinosarcoma; Cholangiocarcinoma | germline | 2 | Jan 01, 2004 | clinvar |